Skip to content
Support Us

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

File photo Shutterstock

Rare disease company to create 200 jobs - at a cost of €450m

It’s one of the largest investments in healthcare in the history of the Irish state.

ALEXION PHARMACEUTICALS, A biopharmaceutical company focused on serving patients with severe and rare disorders, is expanding its Irish operations.

The organisation is set to create 200 jobs upon completion of its €450 million facility in College Park in Blanchardstown, West Dublin.

In a statement released today, Alexion said the expansion project will take place over the next four years and will double its workforce to almost 500.

On top of 200 full-time positions, 800 short-term construction jobs will also be created.

Since it first entered the Irish market in 2011, Alexion has spent €130 million in two facilities – the College Park site and another facility in Athlone.

Martin Shanahan, CEO of IDA Ireland said the project is “one of the largest investments in healthcare in the history of the Irish state”.

Julie O’Neill, Executive Vice President of Alexion’s Global Operations, said the announcement “further underscores our commitment to Ireland and is enabled by our ability to recruit highly competent and professional personnel”.

“Alexion has a unique mission to develop life-transforming therapies for patients with severe and life-threatening ultra-rare disorders,” O’Neill added.

Jobs Minister Richard Bruton TD said the biopharmaceutical sector was “specifically targeted as part of the Action Plan for Jobs, due to the large potential for employment growth which it offers Ireland”.

Hunting for a job? Here are some tips (whether you’re 25 or 50)

A company which did want out of Waterford is now hiring 125 people

Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.

Close
13 Comments
    Install the app to use these features.
    Mute danielplainview
    Favourite danielplainview
    Report
    May 11th 2015, 12:28 PM

    Nice bit of news. The IDA seems to be really on the ball at the moment.

    128
    Install the app to use these features.
    Mute Alan Corlett
    Favourite Alan Corlett
    Report
    May 11th 2015, 3:16 PM

    Yes they were quick congratulating the company for expanding it’s operations, the article didn’t mention the IDA having anything to do with it though.

    7
    Install the app to use these features.
    Mute Billy Cotter
    Favourite Billy Cotter
    Report
    May 11th 2015, 12:40 PM

    A job a day keeps the lMF away

    78
    Install the app to use these features.
    Mute Carina Clarke
    Favourite Carina Clarke
    Report
    May 11th 2015, 12:31 PM

    While this is good news. I wonder how dependent the economy is now on the pharmaceutical industry. I’d say there is danger of it being the bust and dragging Ireland down again if the IDA isn’t planning to be a bit more diverse in the company’s being attracted into Ireland.

    40
    Install the app to use these features.
    Mute James William Chawke
    Favourite James William Chawke
    Report
    May 11th 2015, 1:05 PM

    as long as the world’s population continues to require healthcare there will be a demand for pharmaceutical companies and their products , biopharma is a rapidly growing industry with Ireland being very proactive in attracting these companies from the start. Jobs like this will replace the ones that will be lost from existing pharmaceutical positions in the coming years as we go over the patent cliff.

    100
    Install the app to use these features.
    Mute Alan Corlett
    Favourite Alan Corlett
    Report
    May 11th 2015, 4:18 PM

    And where better to do bioresearch than an Island, you know, containment and all that when it goes horribly wrong (sorry, too many films I’ll put my foil hat back on now)

    3
    Install the app to use these features.
    Mute Brendan Hughes
    Favourite Brendan Hughes
    Report
    May 11th 2015, 2:13 PM

    Going by the headline alone… is there a demand for rare diseases

    5
    Install the app to use these features.
    Mute Stephen Hyland
    Favourite Stephen Hyland
    Report
    May 11th 2015, 3:18 PM

    If a company is willing to invest such a large amount into a facility and work force I’m sure they will be making a return on it. In the case of rare diseases even if a population can have a low percentage affected by the disease, globally it can still mount to a higher percentage of people who need treatment.

    14
    Install the app to use these features.
    Mute Alan Corlett
    Favourite Alan Corlett
    Report
    May 11th 2015, 4:12 PM

    I think Stephen it was a funny as the headline could be taken as the company is MAKING rare diseases, not cures :-)

    1
    See 1 more reply ▾
    Install the app to use these features.
    Mute Brendan Hughes
    Favourite Brendan Hughes
    Report
    May 11th 2015, 5:12 PM

    Thank you Alan. I was just about to reach for a sketch pad.

    1
    Install the app to use these features.
    Mute Sheik Yahbouti
    Favourite Sheik Yahbouti
    Report
    May 11th 2015, 1:19 PM

    Cool. Who is paying the 450 million euro? Run that by me again.

    5
    Install the app to use these features.
    Mute boildyeggs
    Favourite boildyeggs
    Report
    May 11th 2015, 6:38 PM

    Sheikh, what?

    2
    Install the app to use these features.
    Mute John Devoy
    Favourite John Devoy
    Report
    May 11th 2015, 7:30 PM

    A biopharmaceutical company focused on serving patients with severe and rare disorders

    Does anyone not see a problem with the above sentence?

    4
Submit a report
Please help us understand how this comment violates our community guidelines.
Thank you for the feedback
Your feedback has been sent to our team for review.
JournalTv
News in 60 seconds